期刊文献+

肝细胞癌螺旋CT征象与MVD及VEGF表达间关系的研究 被引量:7

Comparison of SCT Features With MVD and Expressions of VEGF in Hepatocellular Carcinoma
原文传递
导出
摘要 目的探讨肝细胞癌(HCC)的螺旋CT征象与瘤内微血管密度(MVD)及血管内皮生长因子(VEGF)表达之间的关系。资料与方法运用免疫组织化学SP法,检测45例经手术切除并病理证实的HCC瘤内MVD及VEGF的表达,所有病例术前均行CT平扫及增强扫描。结果CT征象与MVD、VEGF表达之间的关系:(1)瘤体边缘模糊组和清晰组的HCCMVD分别为50.3±16.2和38.7±13.4,VEGF阳性表达率分别为90.0%(19/21)和54.1%(13/24),组间MVD及VEGF阳性表达率均有显著性差异(P<0.01)。(2)瘤内有坏死不强化组和无坏死组的HCCMVD分别为65.3±17.6和38.2±13.0,VEGF阳性表达率分别为77.8%(7/9)和69.4%(25/36),组间MVD及VEGF阳性表达率均有显著性差异(P<0.01)。(3)有扩散转移组和无扩散转移组的HCCMVD分别为73.9±20.4和40.6±17.1,VEGF阳性表达率分别为100.0%(18/18)和51.8%(14/27),组间MVD及VEGF阳性表达率均有显著性差异(P<0.01)。(4)瘤体直径>5cm和直径≤5cm的HCCMVD分别为54.6±18.4和46.1±16.5,VEGF阳性表达率分别为75.0%(15/20)和68.0%(17/25),组间MVD及VEGF阳性表达率均无显著性差异(P>0.05)。(5)动脉供血型、双重供血型及少供血型HCC的MVD分别为70.6±22.9、65.7±21.6和25.1±13.5,VEGF阳性表达率分别为85.1%(23/27)、63.6%(7/11)和28.6%(2/7)。动脉供血型和双重供血型、双重供血型和少供血型之间VEGF阳性表达率差异均无显著性(P>0.05),动脉供血型或动脉供血型和双重供血型合并组与少供血型之间VEGF阳性表达率差异有显著性(P<0.05);动脉供血型和双重供血型的HCC,其MVD计数均高于少血供型,组间有显著性差异(P<0.01),动脉供血型与双重供血型MVD计数无显著性差异(P>0.1)。结论MVD及VEGF表达与HCC的边缘是否清晰、瘤内有无液化坏死、有无浸润转移及增强类型等CT征象密切相关,反映了新生血管是其生长、发展的形态学基础,在HCC的浸润转移中起重要作用。 Objective We analyse the correlation of SCT features with MVD and expressions of VEGF in order to evaluate the pathology basis of hepatocellular carcinoma(HCC). Materials and Methods 45 cases of HCC proved by pathology were collected in our study. The MVD and expression of VEGF were examined by means of SP immunohistochemical technique. All patients were examined by plain and contrast enhanced CT scanning. Results (1)The MVD and VEGF positive rates in group of HCC with blurred margin were 50.3±16.2,90.0%(19/21),and in those tumors with clear margin were 38.7±17.6,54.1%(13/24). There was significant difference between two groups (P0.05);(2)The MVD and VEGF positive rates were 65.3±17.6,77.8%(7/9) in group of tumor with central necrosis and 38.2±13.0,69.4%(25/36) in tumors without central necrosis,and the difference was statistically significant between two groups(P0.05);(3)The MVD and VEGF positive rates were 73.9±20.4,100.0%(18) in tumors with high infiltration severity and 40.6±17.1,51.8%(14/27) in tumors without infiltration,and the difference was statistically significant(P0.05);(4)The MVD and VEGF positive rates were 54.6±18.4,75.0%(15/20) in tumors with diameter larger than 5.0 cm and 46.1±16.5,68.0%(17/25) in those with diameter less than 5.0 cm,and there was no statistically significant correlation (P0.05);(5)The MVD and VEGF positive rates were 70.6±22.9,85.1%(23/27) in tumors with blood supplied by hepatic arterial,65.7±21.6,63.6%(7/11) in those with blood supplied by both hepatic artery and portal vein,and 25.1±13.5,28.6%(2/7) in those with poor blood supplied. There was statistic difference of VEGF between arterial blood supplied and double blood supplied,and also statistic difference between double blood supplied and poorly blood supplied(P0.05). In HCC with arterial and double blood supply,MVD expression level was higher than that with poor blood supplied (P0.01). Conclusion The CT features of HCC,included border,central necrosis,metastasis and the enhancement patterns,are significantly related to MVD and expression of VEGF. It is indicated that the CT features play an important role in tumor growth and aggressiveness.
作者 姚红霞
出处 《临床放射学杂志》 CSCD 北大核心 2010年第5期611-615,共5页 Journal of Clinical Radiology
关键词 肝细胞癌 螺旋CT 微血管密度 血管内皮生长因子 Hepatocellular carcinoma Spiral Tomography X-ray computed MVD VEGF
  • 相关文献

参考文献15

  • 1陈炽贤.实用放射学[M].北京:人民卫生出版社,1999.1043.
  • 2朱月莉,王滨,史英红.肝细胞癌肿瘤血管生成与螺旋CT增强特征探讨[J].临床放射学杂志,2004,23(1):57-61. 被引量:12
  • 3黄娟,周翔平,刘荣波,陈宪,许崇永,严志汉,徐建英.原发性肝癌血供特点的螺旋CT表现及其与病理学特性的相关性研究[J].中华放射学杂志,2000,34(11):753-756. 被引量:118
  • 4Tsai J, Goldman CK, Gillespie GY,et al. Vascular endothelial growth factor in glioma cell line : induced secretion by EGF, PDGF-BB and b-FGF. J Neurosurg, 1995,82 : 864.
  • 5Benjamin LE, Golijanin D, hin A, et al. Selective ablation of immature blood vessels in established human tumors follows VEGF withdrawal. J Clin Invest, 1999,103 : 159.
  • 6Park YN, Kim YB,Yang KM,et al. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep. Arch Pathol Lab Med ,2000,124:1061.
  • 7EL-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology, 1998,27 : 1554.
  • 8Thomas N, Dirk P. Dynamic contrast enhancement of intracranial tumors with snapshot -FLASH MR Imaging. AJNR, 1993,14:89.
  • 9王小宜,陈长青,陈宇,王润文,彭仁罗.颅内原发性肿瘤动态增强MRI探讨[J].临床放射学杂志,1999,18(7):391-394. 被引量:6
  • 10Itai Y, Matsui O. Blood flow and liver imaging. Radiology, 1997, 202 : 306.

二级参考文献27

  • 1卢光明,杨刚,张福琛,沈复兴,王昌新.动态增强MRI诊断垂体微腺瘤的研[J].中华放射学杂志,1996,30(5):329-332. 被引量:39
  • 2[6]Itai Y,Matsui O.Blood flow and liver imaging.Radiology,1997,202:306
  • 3[7]Hayashi M,Matsui O,Ueda K,et al.Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.AJR,1999,172:969
  • 4[1]Yamashita Y,Mitsuzaki K,Yi T,et al.Small hepatocellular carcinoma in patients with chronic liver damage prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver.Radiology,1996,200:79
  • 5[2]Yamashita Y,Matsukawa T,Arakawa A,et al.US-guided liver biopsy:predicating the effect of interventional treatment of hepatocellular carcinoma.Radiology,1995,196:799
  • 6[3]International Working Party.Terminology of nodular hepatocellular lesions.Hepatology,1995,22:983
  • 7[4]Ueda K,Terata T,Nakanuma Y,et al.Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study.Hum Pathol,1992,23:619
  • 8[5]Rofsky NM,Weinreb JC,Ambrosino MM,et al.Comparison between in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging.JCAT,1996,202:230
  • 9朱世能.肝癌的病理形态与生物学特性[J].汤铡酞 余业勤.原发性肝癌[C].上海医科大学出版社,1999.132-154.
  • 10Hiroki I,Kazuhiko N,kojiro M,et al .Antiangiogenic Gene Therapy for Hcc Using Angiostatin Gene. Hepatology,2003;37(3):696-704.

共引文献199

同被引文献82

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部